Xinsheng Peng

3.3k total citations · 1 hit paper
49 papers, 2.5k citations indexed

About

Xinsheng Peng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xinsheng Peng has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Surgery. Recurrent topics in Xinsheng Peng's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (14 papers) and Spinal Fractures and Fixation Techniques (8 papers). Xinsheng Peng is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (14 papers) and Spinal Fractures and Fixation Techniques (8 papers). Xinsheng Peng collaborates with scholars based in China, United States and India. Xinsheng Peng's co-authors include Dong Ren, Shuai Huang, Wei Guo, Xuenong Zou, Hong Du, Libing Song, Yuhu Dai, Qing Yang, Yubo Tang and Min Wang and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xinsheng Peng

46 papers receiving 2.5k citations

Hit Papers

Exosomes, a New Star for Targeted Delivery 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinsheng Peng China 27 1.8k 1.5k 475 370 248 49 2.5k
Jiaxing Zhang China 28 2.2k 1.3× 1.6k 1.1× 535 1.1× 356 1.0× 182 0.7× 60 3.0k
Beiqin Yu China 29 2.0k 1.1× 1.6k 1.1× 476 1.0× 268 0.7× 188 0.8× 65 2.7k
Sébastien P. Tabruyn Belgium 26 1.3k 0.7× 767 0.5× 587 1.2× 282 0.8× 286 1.2× 36 2.4k
Jianxin Jiang China 34 1.8k 1.0× 1.3k 0.9× 586 1.2× 197 0.5× 233 0.9× 99 2.6k
Patrícia P. Reis Brazil 27 1.2k 0.7× 828 0.6× 422 0.9× 287 0.8× 269 1.1× 80 2.1k
Ting Sun China 19 1.9k 1.1× 1.2k 0.8× 390 0.8× 227 0.6× 115 0.5× 39 2.6k
Xianzhe Liu China 27 1.1k 0.6× 784 0.5× 378 0.8× 206 0.6× 392 1.6× 64 2.2k
Krzysztof Moroz United States 23 854 0.5× 584 0.4× 429 0.9× 302 0.8× 282 1.1× 72 1.8k
Aiping Luo China 29 1.8k 1.0× 998 0.7× 598 1.3× 243 0.7× 226 0.9× 66 2.5k

Countries citing papers authored by Xinsheng Peng

Since Specialization
Citations

This map shows the geographic impact of Xinsheng Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinsheng Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinsheng Peng more than expected).

Fields of papers citing papers by Xinsheng Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinsheng Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinsheng Peng. The network helps show where Xinsheng Peng may publish in the future.

Co-authorship network of co-authors of Xinsheng Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xinsheng Peng. A scholar is included among the top collaborators of Xinsheng Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinsheng Peng. Xinsheng Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xiaofang, et al.. (2025). Immuno-engineered macrophage membrane-coated nanodrug to restore immune balance for rheumatoid arthritis treatment. Acta Biomaterialia. 197. 374–385. 4 indexed citations
2.
3.
Zhu, Yongchun, et al.. (2025). Pyroptosis as a therapeutic target in preeclampsia: current research and future directions. Frontiers in Immunology. 16. 1622550–1622550. 1 indexed citations
4.
Wang, Min, Zhengquan Wu, Xinwen Wang, et al.. (2023). The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1/DDX3X complex in Wnt/β-catenin signaling. Cell Death Discovery. 9(1). 287–287. 9 indexed citations
5.
Cheng, Xing, Jiacheng Chen, Zhong Huang, et al.. (2021). Spinal Cord Parenchyma Vascular Redistribution Underlies Hemodynamic and Neurophysiological Changes at Dynamic Neck Positions in Cervical Spondylotic Myelopathy. Frontiers in Neuroanatomy. 15. 729482–729482. 8 indexed citations
6.
Li, Qiji, Min Wang, Yanqing Hu, et al.. (2021). MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Theranostics. 11(12). 5794–5812. 66 indexed citations
7.
Guo, Wei, David Eglin, Mauro Alini, et al.. (2021). Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair. Carbohydrate Polymers. 277. 118828–118828. 50 indexed citations
8.
Wa, Qingde, Changye Zou, Zhuoyuan Lin, et al.. (2020). Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling. Molecular Therapy — Oncolytics. 17. 267–277. 30 indexed citations
9.
Lin, Kai‐Yuan, Jiacheng Chen, Kuan‐Hung Chen, et al.. (2020). Magnetic resonance imaging and dynamic X-ray’s correlations with dynamic electrophysiological findings in cervical spondylotic myelopathy: a retrospective cohort study. BMC Neurology. 20(1). 367–367. 10 indexed citations
10.
Huang, Sheng, Zemin Ling, Yan Chen, et al.. (2019). A New Diagnostic Medium for Cervical Spondylotic Myelopathy: Dynamic Somatosensory Evoked Potentials. World Neurosurgery. 133. e225–e232. 7 indexed citations
11.
Lü, Fang, Bin Gan, Jin Chen, et al.. (2019). Low-dose tubacin promotes BMSCs proliferation and morphological changes through the ERK pathway.. PubMed. 11(3). 1446–1459. 11 indexed citations
12.
Wa, Qingde, Sheng Huang, Jincheng Pan, et al.. (2019). miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer. Molecular Therapy — Nucleic Acids. 18. 567–579. 49 indexed citations
13.
Ren, Dong, Yuhu Dai, Qing Yang, et al.. (2018). Wnt5a induces and maintains prostate cancer cells dormancy in bone. The Journal of Experimental Medicine. 216(2). 428–449. 140 indexed citations
14.
Zhang, Xin, Dong Ren, Xianqiu Wu, et al.. (2018). miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways. Molecular Therapy — Nucleic Acids. 11. 142–158. 51 indexed citations
15.
Wang, Min, Dong Ren, Wei Guo, et al.. (2014). Loss of miR-100 enhances migration, invasion, epithelialmesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. International Journal of Oncology. 45(1). 362–372. 65 indexed citations
16.
Ren, Dong, Min Wang, Wei Guo, et al.. (2014). Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Cell and Tissue Research. 358(3). 763–778. 119 indexed citations
17.
Chen, Bailing, Yuguang Chen, Junlin Yang, et al.. (2013). Comparison of the Wake-up Test and Combined TES-MEP and CSEP Monitoring in Spinal Surgery. Journal of Spinal Disorders & Techniques. 28(9). 335–340. 15 indexed citations
18.
Guo, Wei, Dong Ren, Xiuting Chen, et al.. (2013). HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA‐145. Journal of Cellular Biochemistry. 114(7). 1606–1615. 85 indexed citations
19.
Huang, Shuai, Wei Guo, Yubo Tang, et al.. (2012). miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. Oncology Reports. 28(5). 1831–1837. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026